BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 4225825)

  • 1. [Action of a new choleretic associated with a spasmolytic and with vitamin B 1 and vitamin PP in therapy of some hepato-biliary disease conditions].
    Bosisio P
    Minerva Med; 1967 Apr; 58(28):1213-9. PubMed ID: 4225825
    [No Abstract]   [Full Text] [Related]  

  • 2. [Imecromone: a new choleretic with antispastic action on Oddi's sphincter. Clinical pharmacology and clinico-statistical study].
    Cremoncini C; Tominz L
    Minerva Med; 1968 Oct; 59(82):4359-68. PubMed ID: 5683717
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical data on the use in surgery of a drug with cholepoietic, eukinetic and antispastic action].
    De bernardis F; Novielli P; Depalma V
    Rass Int Clin Ter; 1966 Jun; 46(12):644-9. PubMed ID: 4230132
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical experiences with a new spasmo-choleretic].
    Meissner O; Quitzow G
    Wien Med Wochenschr; 1966 Oct; 116(40):816-8. PubMed ID: 5925778
    [No Abstract]   [Full Text] [Related]  

  • 5. [Studies of the choleretic and liver-protective effects of the product, "Menabil Complex"].
    Gheorghescu B; Steflea D; Jovin G; Suseanu I
    Fiziol Norm Patol; 1973; 19(1):51-6. PubMed ID: 4266192
    [No Abstract]   [Full Text] [Related]  

  • 6. [Controlled double-blind clinical study of cinnametic acid, a new choleretic agent in hepatobiliary diseases].
    Marchettini G; Maggi P; Benvenuti C
    Clin Ter; 1978 Sep; 86(5):485-94. PubMed ID: 367683
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical observations on a new preparation with hepatoprotective action].
    Fanelli V
    Clin Ter; 1967 Jan; 40(2):145-56. PubMed ID: 4234340
    [No Abstract]   [Full Text] [Related]  

  • 8. [CLINICO-EXPERIMENTAL STUDY OF A NEW CHOLERETIC ASSOCIATED WITH AN ANTI-SPASTIC DRUG AND WITH VITAMIN B1 AND VITAMIN PP].
    BENVESTITO V; MARTELLOTTA G; VIGGIANO N
    Clin Ter; 1963 Aug; 26():331-40. PubMed ID: 14055217
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical studies on the effects of (3-chlor-pyridazinyl-6-thio)-acetic acid diethylamide (Oragallin)].
    Miyoshi A; Ito M; Nakanishi S; Hajiro T; Takeda T
    Naika Hokan; 1968 Mar; 15(3):77-82. PubMed ID: 5691521
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical experiences on the normolipemizing effects of a new pharmaceutical preparation].
    Legnani F
    Policlinico Med; 1966 Feb; 73(1):60-4. PubMed ID: 4223196
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical evaluation of the chloasma treatment using a cholagogue-choleretic].
    D'Amico N
    Rev Bras Med; 1967 Dec; 24(12):1011-4. PubMed ID: 5619919
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of bile duct diseases. Dyskinesias. Chronic inflammation].
    Pontes JF; Tacla M
    Arq Gastroenterol; 1981; 18(4):156-61. PubMed ID: 6751300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Therapeutic action of a new pyrazole-vitamin association compared with that of the vitamin complex alone. Comparative clinico-experimental study].
    Buzzelli G
    Minerva Med; 1971 Dec; 62(98):4906-15. PubMed ID: 4258905
    [No Abstract]   [Full Text] [Related]  

  • 14. [TREATMENT OF SOME HEPATO-BILIARY DISEASES WITH AN ASSOCIATION OF DRUGS WITH CHOLERETIC, CHOLAGOGUE AND HEPATOPROTECTIVE ACTION].
    ABBONA C; GATTO PL; RAFFETTO A; BEZANTE GC
    Arch Maragliano Patol Clin; 1964 Oct; 20():439-56. PubMed ID: 14235315
    [No Abstract]   [Full Text] [Related]  

  • 15. [Cholelithin therapy of angiocholecystites and dyskinesias of bile ducts in children].
    Shmorgun SS; Cherniavskaia VG
    Pediatr Akus Ginekol; 1967; 2():27-9. PubMed ID: 5610524
    [No Abstract]   [Full Text] [Related]  

  • 16. [Use of cholagogic agents in the therapy of patients with dysfunction of the bile-secreting system].
    Nogaller AM; Barkhanova AG; Zakharova GIu
    Klin Med (Mosk); 1989 Sep; 67(9):129-35. PubMed ID: 2685457
    [No Abstract]   [Full Text] [Related]  

  • 17. [Disorder in mechanisms of bile formation and methods of their correction].
    Iakovenko EP; Grigor'ev PIa; Agafonova NA; Iakovenko AV; Prianishnikova AS
    Eksp Klin Gastroenterol; 2003; (6):32-9. PubMed ID: 15065526
    [No Abstract]   [Full Text] [Related]  

  • 18. [Action on the extrahepatic bile ducts of a choleretic compound: imechromone].
    Grossi F; Spada S
    Clin Ter; 1969 Oct; 51(1):41-7. PubMed ID: 5364032
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hymechromone in the treatment of dyskinesia of Oddi's sphincter].
    Pucci C; Galeone M; Puricelli C
    Arch Ital Chir; 1968; 94(5):747-63. PubMed ID: 5732908
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical observations on a new combination of principles regulating disgestion].
    De Liperi E; Brunori F; Coli R; Cartoni F
    Clin Ter; 1967 Mar; 40(6):565-72. PubMed ID: 5601195
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.